FDG-PET/CT scan of inflammatory spondylodiscit... [Ann Rheum Dis. 2005] - PubMed

Supplemental Content

Save items

Related citations in PubMed

Review Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation. [Health Technol Assess. 2007]
Review Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.
McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T. Health Technol Assess. 2007 Aug; 11(28):1-158, iii-iv.
MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib. [Ann Rheum Dis. 2009]
MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib.
Jarrett SJ, Sivera F, Cawkwell LS, Marzo-Ortega H, McGonagle D, Hensor E, Coates L, O'Connor PJ, Fraser A, Conaghan PG, et al. Ann Rheum Dis. 2009 Sep; 68(9):1466-9. Epub 2008 Oct 24.
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis. [Ann Rheum Dis. 2008]
MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
Rudwaleit M, Schwarzlose S, Hilgert ES, Listing J, Braun J, Sieper J. Ann Rheum Dis. 2008 Sep; 67(9):1276-81. Epub 2007 Nov 15.
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response. [Ann Rheum Dis. 2008]
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
Braun J, Baraliakos X, Listing J, Fritz C, Alten R, Burmester G, Krause A, Schewe S, Schneider M, Sörensen H, et al. Ann Rheum Dis. 2008 Mar; 67(3):340-5. Epub 2007 Oct 29.
Review Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? [Arthritis Res Ther. 2005]
Review Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?
Van den Bosch F, De Keyser F, Mielants H, Veys EM. Arthritis Res Ther. 2005; 7(3):121-3. Epub 2005 Apr 11.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylit...
FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment.
Ann Rheum Dis. 2005 Nov ;64(11):1663-5.

PubMed
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and...
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.
Ann Oncol. 2006 Jan ;17(1):131-4. Epub 2005 Oct 14 .

PubMed
LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by ...
LFA-1 is a key determinant for preferential infection of memory CD4+ T cells by human immunodeficiency virus type 1.
J Virol. 2005 Nov ;79(21):13714-24.

PubMed
Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface ...
Mechanism for removal of tumor necrosis factor receptor 1 from the cell surface by the adenovirus RIDalpha/beta complex.
J Virol. 2005 Nov ;79(21):13606-17.

PubMed
Alpha/beta interferon protects against lethal West Nile virus infection by restr...
Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival.
J Virol. 2005 Nov ;79(21):13350-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment.

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information